» Articles » PMID: 24890467

Neurologic Indications for Therapeutic Plasma Exchange: 2013 Update

Overview
Journal J Clin Apher
Specialty Hematology
Date 2014 Jun 4
PMID 24890467
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Neurologists commonly use therapeutic plasma exchange (TPE) to treat a number of conditions. This concise review considers the most common neurologic indications for TPE. It focuses on Guillain-Barré syndrome and myasthenia gravis and also the role of TPE in chronic inflammatory demyelinating polyneuropathy, Lambert-Eaton syndrome, multiple sclerosis, neuromyelitis optica, paraproteinemic polyneuropathy, Sydenham's chorea, and natalizumab-associated progressive multifocal leukoencephalopathy. As with any treatment, the proven efficacy, cost, side effects, and availability must be considered before initiation of therapy.

Citing Articles

A Rare Case of Longitudinally Extensive Transverse Myelitis Following Febrile Illness: A Case Report.

Wettasinghe I, Puthra S, Sugathapala H, Mendis S Cureus. 2024; 16(3):e56316.

PMID: 38629009 PMC: 11020659. DOI: 10.7759/cureus.56316.


COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy.

Gomez F, Mehra A, Ensrud E, Diedrich D, Laudanski K Front Neurosci. 2023; 17:1198327.

PMID: 37712090 PMC: 10498773. DOI: 10.3389/fnins.2023.1198327.


Heterochronic Plasma Transfer: Experimental Design, Considerations, and Technical Challenges.

Ansere V, Bubak M, Miller B, Freeman W Rejuvenation Res. 2023; 26(5):171-179.

PMID: 37551981 PMC: 10611967. DOI: 10.1089/rej.2023.0035.


Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology.

Tonev D, Momchilova A Biomedicines. 2023; 11(2).

PMID: 36830870 PMC: 9953422. DOI: 10.3390/biomedicines11020328.


Intensive Care and Treatment of Severe Guillain-Barré Syndrome.

Shang P, Feng J, Wu W, Zhang H Front Pharmacol. 2021; 12:608130.

PMID: 33995011 PMC: 8113987. DOI: 10.3389/fphar.2021.608130.